HUTCHMED (China) (HMDCF) Other Working Capital Changes (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Other Working Capital Changes came in at -$3.9 million in Q2 2021, down 214.23% year-over-year from $3.4 million in Q2 2020, and down 367.96% quarter-over-quarter from $1.5 million in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Other Working Capital Changes (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Other Working Capital Changes for 4 consecutive years, with -$3.9 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Other Working Capital Changes fell 214.23% year-over-year to -$3.9 million in Q2 2021; TTM through Jun 2021 was -$3.2 million, a 25.35% decrease from a year earlier, with the FY2025 full-year figure at -$49.6 million, down 90.88% from the prior year.
- Other Working Capital Changes was -$3.9 million for Q2 2021 at HUTCHMED (China), down from $1.5 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $27.3 million in Q4 2019 and troughed at -$17.5 million in Q2 2021.
- A 4-year average of $559916.7 and a median of -$918000.0 in 2019 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 187.08% in 2021, down 214.23% in 2021.
- Over 4 years, Other Working Capital Changes stood at -$2.0 million in 2018, then tumbled by 46.67% to -$2.9 million in 2019, then surged by 56.59% to -$1.3 million in 2020, then tumbled by 214.23% to -$3.9 million in 2021.
- The last three Other Working Capital Changes figures came in at -$3.9 million (Q2 2021), $1.5 million (Q1 2021), and -$1.3 million (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -3.93 Mn |
| Jun 30, 2021 | -3.93 Mn |
| Mar 31, 2021 | 1.47 Mn |
| Mar 31, 2021 | 1.47 Mn |
| Jun 30, 2020 | -1.25 Mn |
| Jun 30, 2020 | -1.25 Mn |
| Mar 31, 2020 | 511,000.00 |
| Mar 31, 2020 | 511,000.00 |
| Dec 31, 2019 | -2.88 Mn |
| Dec 31, 2019 | -2.88 Mn |
| Sep 30, 2019 | 1.07 Mn |
| Sep 30, 2019 | 1.07 Mn |
| Jun 30, 2019 | -733,000.00 |
| Jun 30, 2019 | -733,000.00 |
| Mar 31, 2019 | 1.84 Mn |
| Mar 31, 2019 | 1.84 Mn |
| Dec 31, 2018 | -1.97 Mn |
| Dec 31, 2018 | -1.97 Mn |
| Sep 30, 2018 | 736,000.00 |
| Sep 30, 2018 | 736,000.00 |